REFERENCES
- Rupnik M, Brazier JS, Duerden BI, Grabnar M, Stubbs SU. Comparison of toxinotying and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes. Microbiol-ogy 2001; 147: 439–447.
- Rupnik M, Kato N, Grabnar M, Kato H. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003; 41: 1118–1125.
- O'Neill GL, Ogunsola FT, Brazier JS, Duerden BI. Modifi-cation of PCR ribotyping method for application as a routine typ-ing scheme for Clostridium difficile. Anaerobe 1996; 2: 205–209.
- Jamal WY, Mokaddas EM, Verghese TL, Rotimi VO. In vitro activity of 15 antimicrobial agents against clinical isolates of Clostridium difficile in Kuwait. Int J Antimicrob Chemother 2002; 20: 270–274.
- Rotimi VO, Mokaddas EM, Jamal WY, Verghese TL, El-Din K, Junaid TA. Hospital-acquired Clostridium difficile in-fection amongst ICU and Burn patients in Kuwait. Med Principles Pract 2002; 11: 23–28.
- Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR tar-geted to the 165-235 rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different ribotypes. J Clin Microbiol 1999; 37, 461–463.
- Geric B, Rupnik M, Gerding DN, Grabnar M, Johnson S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J Med Microbiol 2004; 53: 887–894.
- Rupnik M, Braun V, Soehn F, Janc M, Hofstetter M, Laufenberg-Feldmann R, von Eichel-Streiber C. Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile. FEMS Microbiol Lett 1997; 148: 197–202.
- National Committee of Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing for anaerobic bac-teria. In: Approved Standard M11-A4, 4th ed. Wayne, Pa: Na-tional Committee for Clinical Laboratory Standards.1997.
- Mutlu E, Wroe AJ, Sanchez-Hurtado K, Brazier JS, Pox-ton IR. Molecular characterization and antimicrobial susceptibil-ity patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland. J Med Microbiol 2007; 56: 921–929.
- Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphisim in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002; 40, 3470–3475.
- Baines SD, O'Connor R, Freeman J, Fawley WN, Har-manus C, Mastrantonio P, Kuijper EJ, et al. Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 2008; 62: 1046–52.
- Rotimi VO, Jamal WY, Mokaddas EM, Brazier JS, Johny M, Duerden BI. Prevalent PCR ribotypes of clinical and environ-mental strains of Clostridium difficile isolated from intensive therapy unit patients in Kuwait. J Med Microbiol 2003; 52: 705–709
- Urban E, Brazier JS, Soki J, Nagy E, Duerden BI. 2001. PCR ribotyping of clinically important Clostridium difficile strains from Hungry. J Med Microbiol 2001; 50: 1082–1086.
- Martirosian G, Kuipers S, Verbrugh H, van Belkum A, Meisel-Mikolajczyk F. PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital. J Clin Microbiol 1995; 33: 2016–2021.
- Health Protection Agency. (2006). Clostridium difficile findings and recommendations from a review of the epidemiol-ogy and a survey of Directors of Infection Prevention and Con-trol in England. htpp://www.hpa.org.uk/infections/topics_az/ clostridium_difficile/documents/Clostridium_difficile_survey_find- ings_recommendations.pdf.
- Kuijper EJ, Barbut F, Brazier JS, Kleinkauf N, Eckmanns T, Lambert M, Drudy D et al. Update of Clostridium difficile infections due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008; 13 (31). Pii: 18942.
- Goorhuis A, Van der Kooi T, Vaessen N, Dekker FW, Van den Berg R, Harmanus C, van den Hof S et al. Spread and epi-demiology of Clostridium difficile polymerase chain reaction ri-botype 027/toxinotype III in The Netherlands. Clin Infect Dis 2007; 45: 695–703.